Declining Approval for Lilly’s Donanemab, FDA Refers the Antiamyloid to Adcomm Scrutiny

Rather than handing out the approval Lilly was hoping for, the FDA will put donanemab, the company’s antiamyloid contender, through its paces in an upcoming advisory committee meeting. Source: Drug…

Continue ReadingDeclining Approval for Lilly’s Donanemab, FDA Refers the Antiamyloid to Adcomm Scrutiny

Software Error Causes Recall of Baxter ExactaMix for Over-Delivery of Ingredients

Due to an overfill feature in mixing medical ingredients potentially leading to an “over-delivery” and adverse health consequences, Baxter Healthcare has recalled for product correction its ExactaMix Pro 1200 and…

Continue ReadingSoftware Error Causes Recall of Baxter ExactaMix for Over-Delivery of Ingredients

Biden ‘Strike Force’ Launches Public Inquiry Into Healthcare Practices

The FTC, Department of Justice (DOJ) and HHS have jointly launched a cross-government public inquiry into private-equity and other corporations’ increasing control over healthcare, further signaling the Biden administration’s commitment…

Continue ReadingBiden ‘Strike Force’ Launches Public Inquiry Into Healthcare Practices